In the present study, we compared FOS promoter activity with four tumor-specific promoters in human glioma cell lines and astrocytes, and tested the biologic activity of recombinant adenovirus containing suicide genes driven by FOS promoter, including selective killing efficacy in vitro and tumor inhibition rate in vivo. The gene discussed is FOS; the disease is neoplasm.